Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007 May;5(5):323-5.
doi: 10.1016/j.cmet.2007.04.006.

Targeting fat to prevent diabetes

Affiliations
Comment

Targeting fat to prevent diabetes

Jaswinder K Sethi et al. Cell Metab. 2007 May.

Abstract

An emerging view is that obesity causes metabolic problems when adipose tissue fails to meet the increased demands for fat storage. A study in this issue of Cell Metabolism (Waki et al., 2007) has identified harmine as a proadipogenic small molecule that promotes energy expenditure in white adipose tissue and delays the onset of obesity-associated diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Effects of Harmine on PPARγ Expression in db/db Mice
Harmine is a naturally occurring β-carboline alkaloid found in Syrian rue (Peganum harmala) and other plants. A small-molecule library screen (Waki et al., 2007) has identified it as a proadipogenic molecule that acts by inducing PPARγ expression. Obese (db/db) mice treated with harmine show a delay in the onset of diabetes, coincident with increased oxygen consumption and thermogenesis. A 2-fold increase in PPARγ levels was selectively seen in white adipose tissue, while there was a 50% decrease in PPARγ levels in the liver and no change in muscle, brown adipose tissue, or kidney. The effect of harmine on PPARγ expression in the brain and pancreas is currently unknown. Peganum harmala image reproduced from http://commons.wikimedia.org/.

Comment on

References

    1. Cawthorn WP, Heyd F, Hegyi K, Sethi JK. Cell Death Differ. 2007 Published online April 20, 2007. 10.1038/sj.cdd.4402127. - PMC - PubMed
    1. Cooper EJ, Hudson AL, Parker CA, Morgan NG. Eur. J. Pharmacol. 2003;482:189–196. - PubMed
    1. Gray SL, Dalla Nora E, Backlund EC, Manieri M, Virtue S, Noland RC, O’Rahilly S, Cortright RN, Cinti S, Cannon B, Vidal-Puig A. Endocrinology. 2006;147:5708–5714. - PubMed
    1. Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M. Exp. Cell Res. 2005;304:91–104. - PubMed
    1. Liu J, Wang H, Zuo Y, Farmer SR. Mol. Cell. Biol. 2006;26:5827–5837. - PMC - PubMed